Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年5月26日
	新闻
	Multiple signaling pathways in the frontiers of Lung cancer progression Frontiers Lung cancer is a prevalent malignant tumor and the leading cause of cancer-related mortality worldwide. LC is a complex respiratory condition that ... 标记为不相关
	ASCO 25: Jazz, PharmaMar reveal SCLC survival data | pharmaphorum Pharmaphorum Jazz and PharmaMar have revealed the overall survival data with their small-cell lung cancer drug Zepzelca, described as a 'milestone' in the ... 标记为不相关
	Relationship between mutation profile detected by next-generation sequencing and ... - EurekAlert! EurekAlert! Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like ... 标记为不相关
	Expanding access to genomic testing in lung cancer - IndiaMedToday IndiaMedToday Even as advances in lung cancer treatment have improved survival rates, the focus is now shifting toward enhancing quality of care through more ... 标记为不相关
	Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ... Taiwan News DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) ... 标记为不相关
	Progress In The Effort To Improve Outcomes In SCLC - Citeline News & Insights Citeline News & Insights Several drug makers are working to bring new advances to small-cell lung cancer, a fast-growing cancer with limited treatment options. 标记为不相关
	Early Detection Key to Beating Lung Cancer: Dr. George - MyNation MyNation According to the World Health Organization (WHO), lung cancer claims the lives of more than 1.8 million people every year, making it the leading cause ... 标记为不相关
	Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for ... ResearchGate Summary data regarding lung cancer outcomes and skin bacteria were sourced from the GWAS and GWAS catalog ... [Show full abstract] ... 标记为不相关
	A review of multimodule stimuli-responsive chitosan-incorporated lipid-based micro ... ScienceDirect.com A.J. Cole et al. Motion Management for Radical Radiotherapy in non-small cell lung Cancer. Clin. Oncol. ( ... 标记为不相关
	Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic ... Journal of Translational Medicine - BioMed Central Furthermore, xenograft experiments involving colorectal cancer, lung cancer ... lung tumor development by enhancing inflammation, tumor cell ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈